Compass Pathways Appoints a New CEO
George Goldsmith will be replaced as Compass Pathways CEO. Is this good or bad news?
George Goldsmith will be replaced as Compass Pathways CEO. Is this good or bad news?
Deficiancies in good clinical practices and accurate record keeping stops an MDMA clinical trial in its tracks
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.